Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP27735.RA4eUyAYbqc3mI6EqtLX5xT9kEIkles3a-EKzVQ8OpuTw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP27735.RA4eUyAYbqc3mI6EqtLX5xT9kEIkles3a-EKzVQ8OpuTw130_assertion type Assertion NP27735.RA4eUyAYbqc3mI6EqtLX5xT9kEIkles3a-EKzVQ8OpuTw130_head.
- NP27735.RA4eUyAYbqc3mI6EqtLX5xT9kEIkles3a-EKzVQ8OpuTw130_assertion description "[Incubation with the nonspecific cyclooxygenase (COX) inhibitor indomethacin or the COX1 inhibitor valeryl salicylate, but not the COX-2 inhibitor NS-398, significantly improved relaxation to acetylcholine in HF mice (maximum relaxation = 74 +/- 5, 91 +/- 1, and 58 +/- 5%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27735.RA4eUyAYbqc3mI6EqtLX5xT9kEIkles3a-EKzVQ8OpuTw130_provenance.
- NP27735.RA4eUyAYbqc3mI6EqtLX5xT9kEIkles3a-EKzVQ8OpuTw130_assertion evidence source_evidence_curated NP27735.RA4eUyAYbqc3mI6EqtLX5xT9kEIkles3a-EKzVQ8OpuTw130_provenance.
- NP27735.RA4eUyAYbqc3mI6EqtLX5xT9kEIkles3a-EKzVQ8OpuTw130_assertion SIO_000772 20304815 NP27735.RA4eUyAYbqc3mI6EqtLX5xT9kEIkles3a-EKzVQ8OpuTw130_provenance.
- NP27735.RA4eUyAYbqc3mI6EqtLX5xT9kEIkles3a-EKzVQ8OpuTw130_assertion wasDerivedFrom ctd_human-20130708 NP27735.RA4eUyAYbqc3mI6EqtLX5xT9kEIkles3a-EKzVQ8OpuTw130_provenance.
- NP27735.RA4eUyAYbqc3mI6EqtLX5xT9kEIkles3a-EKzVQ8OpuTw130_assertion wasGeneratedBy ECO_0000218 NP27735.RA4eUyAYbqc3mI6EqtLX5xT9kEIkles3a-EKzVQ8OpuTw130_provenance.